The number of cannabis-based medicines authorized by Anvisa for sale in pharmacies in Brazil has now reached 11.
Not all have been placed in retail yet, but there is a forecast for the second quarter, according to BRCann (an association that brings together companies operating in the area).
Five of them have already started to be distributed.
“This year, doctors will have five options on the shelves. Medicines in pharmacies leave doctors more comfortable to prescribe”, says Tarso Araújo, executive director of BRCann.
Despite the increase in supply, it is still difficult to estimate the price level, according to him.
“The products are not subject to the price control of registered medicines. These values ​​are still unknown”, he says.
your subscription can be worth even more
Do you already know the advantages of being a Folha subscriber? In addition to having access to reports and columns, you have exclusive newsletters (find out here). You can also download our free app from the Apple Store or Google Play to receive alerts on the top news of the day. Your subscription helps us to make independent and quality journalism. Thanks!
your subscription is worth a lot
More than 180 reports and analyzes published each day. A team with more than 120 columnists. A professional journalism that supervises the public power, conveys useful and inspiring news, counterpoints the intolerance of social networks and draws a clear line between truth and lie. How much does it cost to help produce this content?
sign the sheet
I have over 8 years of experience in the news industry. I have worked for various news websites and have also written for a few news agencies. I mostly cover healthcare news, but I am also interested in other topics such as politics, business, and entertainment. In my free time, I enjoy writing fiction and spending time with my family and friends.
